Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
March 21, 2017
Patent Application Number
14987374
Date Filed
January 4, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
Monoclonal antibodies that bind and inhibit activation of epidermal growth factor receptor related member ErbB3/HER3 are disclosed. The antibodies can be used to treat cell proliferative diseases and disorders, including certain forms of cancer, associated with activation of ErbB3/HER3.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
